HIF1A and neoplasm: Suppression of HIF-1 by RNAi, antisense oligonucleotide, and the dominant negative form of HIF-1 showed anti-tumor effects in various preclinical models including pancreatic cancer, tongue squamous cell carcinoma, and gastric cancer [56,57,58].